These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31568558)

  • 21. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.
    Bedford P; Hauke DJ; Wang Z; Roth V; Nagy-Huber M; Holze F; Ley L; Vizeli P; Liechti ME; Borgwardt S; Müller F; Diaconescu AO
    Neuropsychopharmacology; 2023 Jul; 48(8):1175-1183. PubMed ID: 37185950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.
    Müller F; Lenz C; Dolder P; Lang U; Schmidt A; Liechti M; Borgwardt S
    Acta Psychiatr Scand; 2017 Dec; 136(6):648-657. PubMed ID: 28940312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 25. LSD alters dynamic integration and segregation in the human brain.
    Luppi AI; Carhart-Harris RL; Roseman L; Pappas I; Menon DK; Stamatakis EA
    Neuroimage; 2021 Feb; 227():117653. PubMed ID: 33338615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
    Gresch PJ; Strickland LV; Sanders-Bush E
    Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
    Nichols CD; Garcia EE; Sanders-Bush E
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular insights into psychedelic drug action.
    Slocum ST; DiBerto JF; Roth BL
    J Neurochem; 2022 Jul; 162(1):24-38. PubMed ID: 34797943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.
    Nichols CD; Sanders-Bush E
    Neuropsychopharmacology; 2002 May; 26(5):634-42. PubMed ID: 11927188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.
    De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G
    J Neurosci; 2021 Feb; 41(5):891-900. PubMed ID: 33257322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural correlates of the LSD experience revealed by multimodal neuroimaging.
    Carhart-Harris RL; Muthukumaraswamy S; Roseman L; Kaelen M; Droog W; Murphy K; Tagliazucchi E; Schenberg EE; Nest T; Orban C; Leech R; Williams LT; Williams TM; Bolstridge M; Sessa B; McGonigle J; Sereno MI; Nichols D; Hellyer PJ; Hobden P; Evans J; Singh KD; Wise RG; Curran HV; Feilding A; Nutt DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4853-8. PubMed ID: 27071089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD.
    Deco G; Cruzat J; Cabral J; Knudsen GM; Carhart-Harris RL; Whybrow PC; Logothetis NK; Kringelbach ML
    Curr Biol; 2018 Oct; 28(19):3065-3074.e6. PubMed ID: 30270185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.
    Müller F; Holze F; Dolder P; Ley L; Vizeli P; Soltermann A; Liechti ME; Borgwardt S
    Neuropsychopharmacology; 2021 Feb; 46(3):545-553. PubMed ID: 33219313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.